Evidence map›Paper›PMID 41032250›Full record

ArticleThe Gerontologist2025

Advancing early and equitable detection of dementia: key learnings/challenges, recent innovations, and future directions.

Joshua Chodosh, Soo Borson, Alexandra Nordyke, Simona C Kwon, Karyn Marsh, Alok Vedvyas, Matthew Lee

Abstract read
In one paragraph

Article in The Gerontologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joshua ChodoshDivision of Geriatric Medicine and Palliative Care, New York University Grossman School of Medicine, New York, New York, United States.
Soo BorsonKeck School of Medicine, University of Southern California, Los Angeles, California, United States.
Alexandra NordykeDivision of Geriatric Medicine and Palliative Care, New York University Grossman School of Medicine, New York, New York, United States.
Simona C KwonDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, United States.ORCID 0000-0003-2398-704X
Karyn MarshDepartment of Neurology, New York University Grossman School of Medicine, New York, New York, United States.
Alok VedvyasDepartment of Neurology, New York University Grossman School of Medicine, New York, New York, United States.
Matthew LeeDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, United States.

Funding

Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mary Sherman Mittelman · 2020 to 2026
$28.4M
ACL HHS U18DP006911CDC HHSHHS NU58DP006911NCCDPHP CDC HHS U18 DP006911NIA NIH HHS P30 AG066512
6 · The paper itself

Abstract

Worldwide, over half of all individuals with dementia are undiagnosed. In the United States, racial, ethnic, and economic inequities mirror global findings, with higher rates of missed and delayed diagnosis and poorer diagnostic quality among minoritized and disadvantaged groups. For example, delayed diagnosis is more prevalent among people identifying as non-Hispanic Black or Latino than non-Hispanic White. Systematic efforts to improve detection can increase diagnosis rates; there is broad consensus that earlier detection and initiation of focused care and support services benefit both affected individuals and their loved ones. Systemic under-detection and its contributions to persistent population-level suffering underscore the importance of early detection of dementia as a key public health issue. Improving early detection calls for comprehensive, coordinated responses from local, regional, and national public health systems in partnership with health care delivery systems and community-based organizations. The Public Health Center of Excellence on Early Detection of Dementia (PHCOE on EDD), funded by the Centers for Disease Control and Prevention (CDC), is a national resource to promote understanding and implementation of evidence-based and evidence-informed public health strategy for early detection of dementia. We, together with the PHCOEs on Dementia Risk Reduction and Dementia Caregiving, and nearly four dozen state and local initiatives, seek to operationalize the priorities of the Building Our Largest Dementia Infrastructure for Alzheimer's Act and National Healthy Brain Initiative, established by federal legislation in 2018 and 2024. Our efforts support the CDC's mandate to build a national public health infrastructure for brain health and dementia.

Indexed as

DementiaEarly DiagnosisHealthcare DisparitiesDelayed DiagnosisHumansPublic HealthUnited StatesAlzheimer’s diseaseCognitionDementiaEarly detection of dementia

Identifiers

PMID41032250
PMCPMC12736990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.